Ledger.Open graph →
SEC Form D · filed November 12, 2025

Phio Pharmaceuticals Corp

Offering
$25.9M
Sold
$1.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
KING OF PRUSSIA, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Curtis A. Lockshin, Ph.D · KING OF PRUSSIA, PADirectorPatricia A. Bradford · KING OF PRUSSIA, PADirectorRobert J. Bitterman · Marlborough, MAExec · DirectorJonathan A. Freeman · KING OF PRUSSIA, PADirectorLisa H. Carson · King of Prussia, PAExecDavid H. Deming · KING OF PRUSSIA, PADirectorCurtis A. Lockshin, Ph.D · KING OF PRUSSIA, PADirectorPatricia A. Bradford · KING OF PRUSSIA, PADirectorRobert J. Bitterman · VILLANOVA, PAExec · DirectorLisa H. Carson · King of Prussia, PAExecDavid H. Deming · KING OF PRUSSIA, PADirectorJonathan A. Freeman · KING OF PRUSSIA, PADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗